External resources
Current NHS consultant posts held
Consultant Ophthalmic Surgeon, Glaucoma Service, Moorfields Eye Hospital NHS Foundation Trust, London, U.K.
Director, Glaucoma Service, Moorfields Eye Hospital NHS Foundation Trust, London, U.K.
Associate Professor, Institute of Ophthalmology, University College London, U.K.
Research interests
Translational laboratory research towards novel treatments for glaucoma and stem cell therapies; Laboratory models of glaucomatous optic nerve damage; Development of stem cell-based therapies for glaucoma; Outcomes of glaucoma surgery and clinical trials.
Awards received
Medical Research Council (UK) / RCSEd Clinical Research Training Fellow (2008-2011)
PhD (Retinal Stem Cell Biology), University College London (2011)
National Institute for Health Research (NIHR) Academic Clinical Lectureship (2011-14)
Fulbright / Fight for Sight Research Scholarship, Casey Eye Institute, Portland, Oregon, USA (2014-16)
Publications
Publications (2022-3)
• Clinical risk stratification in glaucoma. Poostchi A, Kastner A, Konstantakopoulou E, Gazzard G, Jayaram H. Clinical risk stratification in glaucoma. Eye (Lond). 2023 Mar 14:1–7.
• Glaucoma Drainage Device surgery outcomes in children with uveitic glaucoma. Gkaragkani E, Jayaram H et al. Glaucoma Drainage Device surgery outcomes in children with uveitic glaucoma. Am J Ophthalmol. 2023 Feb 21:S0002-9394(23)00050-8.
• Comparing phacoemulsification alone with phacoemulsification and endoscopic cyclophotocoagulation: The CONCEPT study methodology. Sherman T, Rodrigues I, Goyal S, Alaghband P, Bloom P, Barton K, Jayaram H et al. Ophthalmol Glaucoma 2023 Mar 15;S2589-4196(23)00062-5.
• Nikita E, Gazzard G, Sim DA, Fasolo S, Kortum K, Jayaram H. Expansion of Patient Eligibility for Virtual Glaucoma Clinics: A Long-Term Strategy to Increase the Capacity of High Quality Glaucoma Care. Br J Ophthalmol. 2023 Jan;107(1):43-48.
• Preserflo Microshunt Implant for the treatment of refractory uveitic glaucoma: 36-month outcomes.Microshunt for the treatment of uveitic glaucoma. Triolo G, Wang J, Aguilar-Munoa S, Jayaram H. Eye 2023 (in press)
• Koenig S., Montesano G, Fang CEH, Crabb D, Jayaram H, Clarke J. Effect of trabeculectomy on the rate of progression of visual field damage. Eye (Lond). 2022 Dec 7. doi: 10.1038/s41433-022-02312-y
• Azuara-Blanco A, Carlisle A, Jayaram H et al. Surgical innovation in ophthalmology: challenges and opportunities. Eye 2022 Dec 7
• Azuara-Blanco A, Carlisle A, O’Donnell M, Jayaram H et al. Design and conduct of randomized clinical trials evaluating surgical innovations in ophthalmology: A systematic review. Am J Ophthalmol 2022 Dec 21;S0002-9394(22)00503-7
• Konstantakopoulou E, Kastner A, Gazzard G, Jayaram H. Validation of the RCOphth and UKEGS glaucoma risk stratification tool 'GLAUC-STRAT-fast'. Br J Ophthalmol. 2022 May 9:bjophthalmol-2021-320968
• Jayaram H, Baneke A, Adesanya J, Gazzard G. Managing Risk in the Face of Adversity: Design and Outcomes of Rapid Glaucoma Assessment Clinics During a Pandemic Recovery. Eye (Lond). 2022 Sep;36(9):1799-1803.
• Bicket AK, Le JT, Azuara-Blanco A, Gazzard G, Wormald R, Bunce C, Hu K, Jayaram H et al. Minimally Invasive Glaucoma Surgical Techniques for Open-Angle Glaucoma: An Overview of Cochrane Systematic Reviews and Network Meta- analysis. JAMA Ophthalmol. 2021 Sep 1;139(9):983-989.